FDA Clearance Sparks Femasys Surge; THOR Industries Tops Estimates
- September 25th, 2023
- 382 views
Shares of Femasys Inc. (Nasdaq: FEMY) surged by over 100% in after-hours trading following the company's announcement of receiving 510(k) Clearance from the United States Food and Drug Administration (FDA) for its groundbreaking infertility treatment, FemaSeed. This innovative solution is designed to deliver sperm directly to the fallopian tube, targeting the site of conception in women.
$FEMY was trading at $0.97 in the extended session, up $0.63 (+192.52%)
In other news, THOR Industries, Inc. (NYSE: THO), a leading recreational vehicle manufacturer, reported fourth-quarter fiscal 2023 earnings of $1.68 per share, surpassing the consensus EPS estimate of $0.96. The company's quarterly sales reached $2.74 billion, beating analysts' revenue projection of $2.42 billion.
Additionally, THOR Industries has provided guidance for full-year fiscal 2024, with expected diluted EPS in the range of $6.25 to $7.25, compared to the consensus EPS estimate of $7.12 for the period.
$THO was trading at $93.66 in after-hours, down $1.16 (-1.22%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024Key Metrics: CyberArk Software, Hudbay Minerals, and Sonos Earnings Due
November 11th, 2024Earnings: What to Expect from Occidental Petroleum, Rocket Lab, and CAE
November 10th, 2024Earnings Countdown: Home Depot, Sea Limited, and Natera in the Spotlight
November 10th, 2024Ahead of Earnings: DoorDash, MetLife, and Exelon in the Spotlight
October 27th, 2024
Member Login